UN

Uni-Bio Science Group Ltd

Develops biopharma therapies for endocrinology, ophthalmology, and dermatology needs.

690 | HKEX

Overview

Corporate Details

ISIN(s):
KYG9198H1406
LEI:
Country:
Hong Kong
Address:
N/A
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Uni-Bio Science Group Ltd. is an integrated biopharmaceutical company focused on the research, development, manufacturing, and commercialization of innovative therapies. The company's core research areas include endocrinology (such as diabetes and osteoporosis), ophthalmology (addressing conditions like dry eye and corneal injury), and dermatology, including medical aesthetics and wound healing. Uni-Bio Science operates across four integrated technology platforms: new drug research, clinical development, production and quality control, and commercial sales. Its pipeline features a differentiated portfolio of biological and chemical drugs, including proprietary treatments like Bogutai® and Uni-GLP-1, as well as cosmetic peptides and stem cell exosomes, aiming to address significant unmet medical needs and improve patient quality of life.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all Uni-Bio Science Group Ltd filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Uni-Bio Science Group Ltd

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Uni-Bio Science Group Ltd via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

JEIL PHARMA HOLDINGS INC. Logo
Develops and distributes APIs, generics, and modified drugs, specializing in injections.
South Korea
002620
JETEMA Co.,Ltd. Logo
Research-driven developer of aesthetic toxins, dermal fillers, and threads.
South Korea
216080
Develops and manufactures high-tech drugs for cancer, diabetes, and a range of diseases.
South Korea
007370
JOHNSON & JOHNSON Logo
Develops innovative medicines and medical technologies for complex diseases and personalized care.
United States of America
JNJ
Journey Medical Corp Logo
A pharmaceutical firm commercializing prescription drugs and generics for dermatology.
United States of America
DERM
JUPITER NEUROSCIENCES, INC. Logo
Pharma firm developing resveratrol treatments for neuroinflammation and rare diseases.
United States of America
JUNS
JW LIFESCIENCE CORPORATION Logo
A leading developer and manufacturer of infusion solutions, from basic IV fluids to complex nutrients.
South Korea
234080
JW SHINYAK CORPORATION Logo
Develops specialty medicines for the dermatology, urology, and otolaryngology clinical markets.
South Korea
067290
Jyong Biotech Ltd. Logo
Develops plant-derived drugs for urinary system diseases, with a lead candidate in Phase III trials.
United States of America
MENS
Kadimastem Ltd. Logo
Develops off-the-shelf stem cell therapies for diabetes & neurodegenerative diseases.
Israel
KDST

Talk to a Data Expert

Have a question? We'll get back to you promptly.